| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |